title: Rituximab reduces risk for relapse in patients with thrombotic thrombocytopenic purpura.
authors.affiliation: Department of Biostatistics and Epidemiology, College of Public Health and Hematology-Oncology Section, Department of Medicine, College of Medicine, The University of Oklahoma Health Sciences Center, Oklahoma City, OK; and.
authors.forename: Evaren E
authors.initials: EE
authors.lastname: Page
authors.affiliation: Department of Hematology and Central Hematology Laboratory, University Hospital of Bern, Department of Clinical Research, University of Bern, Bern, Switzerland.
authors.forename: Johanna A
authors.initials: JA
authors.lastname: Kremer Hovinga
authors.affiliation: Department of Biostatistics and Epidemiology, College of Public Health and.
authors.forename: Deirdra R
authors.initials: DR
authors.lastname: Terrell
authors.affiliation: Department of Biostatistics and Epidemiology, College of Public Health and.
authors.forename: Sara K
authors.initials: SK
authors.lastname: Vesely
authors.affiliation: Department of Biostatistics and Epidemiology, College of Public Health and Hematology-Oncology Section, Department of Medicine, College of Medicine, The University of Oklahoma Health Sciences Center, Oklahoma City, OK; and.
authors.forename: James N
authors.initials: JN
authors.lastname: George
mesh_terms: D000071120:ADAMTS13 Protein / Q000032:analysis; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000328:Adult; D000368:Aged; D005260:Female; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D010951:Plasma Exchange; D011697:Purpura, Thrombotic Thrombocytopenic / Q000175:diagnosis / Q000188:drug therapy / Q000517:prevention & control / Q000628:therapy*; D012008:Recurrence; D000069283:Rituximab / Q000627:therapeutic use*; D055502:Secondary Prevention / Q000379:methods; D055815:Young Adult
chemical_list: D000305:Adrenal Cortex Hormones; D007155:Immunologic Factors; D000069283:Rituximab; D000071120:ADAMTS13 Protein